These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 2269603)

  • 1. Mechanisms of action of ECT in Parkinson's disease: possible role of pineal melatonin.
    Sandyk R
    Int J Neurosci; 1990 Jan; 50(1-2):83-94. PubMed ID: 2269603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pineal melatonin functions: possible relevance to Parkinson's disease.
    Sandyk R
    Int J Neurosci; 1990 Jan; 50(1-2):37-53. PubMed ID: 2269599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Weak magnetic fields antagonize the effects of melatonin on blood glucose levels in Parkinson's disease.
    Sandyk R
    Int J Neurosci; 1993 Jan; 68(1-2):85-91. PubMed ID: 8063518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pineal melatonin and sensory symptoms in Parkinson disease.
    Sandyk R
    Ital J Neurol Sci; 1989 Aug; 10(4):399-403. PubMed ID: 2676905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between ECT nonresponsiveness and calcification of the pineal gland in bipolar patients.
    Sandyk R; Pardeshi R
    Int J Neurosci; 1990 Oct; 54(3-4):301-6. PubMed ID: 2265980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Electroconvulsive therapy in the treatment of Parkinson disease].
    Jeanneau A
    Encephale; 1993; 19(5):573-8. PubMed ID: 8306926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased pineal Fdopa uptake is related to severity of Parkinson's disease--a PET study.
    Ghaemi M; Rudolf J; Hilker R; Herholz K; Heiss WD
    J Pineal Res; 2001 May; 30(4):213-9. PubMed ID: 11339510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electroconvulsive therapy (ECT) in Parkinson's disease: ECS and dopamine enhancement.
    Cumper SK; Ahle GM; Liebman LS; Kellner CH
    J ECT; 2014 Jun; 30(2):122-4. PubMed ID: 24810775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ECT for Parkinson's disease.
    Popeo D; Kellner CH
    Med Hypotheses; 2009 Oct; 73(4):468-9. PubMed ID: 19660875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pineal gland and cancer.
    Ronco AL; Halberg F
    Anticancer Res; 1996; 16(4A):2033-9. PubMed ID: 8712739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The human pineal gland and melatonin in aging and Alzheimer's disease.
    Wu YH; Swaab DF
    J Pineal Res; 2005 Apr; 38(3):145-52. PubMed ID: 15725334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unilateral ultra-brief pulse electroconvulsive therapy for depression in Parkinson's disease.
    Williams NR; Bentzley BS; Sahlem GL; Pannu J; Korte JE; Revuelta G; Short EB; George MS
    Acta Neurol Scand; 2017 Apr; 135(4):407-411. PubMed ID: 27241213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Locus coeruleus-pineal melatonin interactions and the pathogenesis of the "on-off" phenomenon associated with mood changes and sensory symptoms in Parkinson's disease.
    Sandyk R
    Int J Neurosci; 1989 Nov; 49(1-2):95-101. PubMed ID: 2691423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accelerated growth of malignant melanoma by levodopa in Parkinson's disease and role of the pineal gland.
    Sandyk R
    Int J Neurosci; 1992 Mar; 63(1-2):137-40. PubMed ID: 1342025
    [No Abstract]   [Full Text] [Related]  

  • 15. Pineal melatonin functions and the depression of Parkinson's disease: a hypothesis.
    Sandyk R
    Int J Neurosci; 1990 Mar; 51(1-2):73-7. PubMed ID: 2265910
    [No Abstract]   [Full Text] [Related]  

  • 16. [Electroconvulsive therapy in Parkinson disease. Description of three cases].
    Avila A; Sastre F; Cardona X; Maho P; Bello J; Sancho I
    Neurologia; 1997; 12(7):313-6. PubMed ID: 9432202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Stroke and epiphysis].
    Arushanian EB; Naumov SS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(12 Suppl 2):67-74. PubMed ID: 20879108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A therapeutic role for melatonin antagonism in experimental models of Parkinson's disease.
    Willis GL; Armstrong SM
    Physiol Behav; 1999 Jul; 66(5):785-95. PubMed ID: 10405106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvements in both psychosis and motor signs in Parkinson's disease, and changes in regional cerebral blood flow after electroconvulsive therapy.
    Usui C; Hatta K; Doi N; Kubo S; Kamigaichi R; Nakanishi A; Nakamura H; Hattori N; Arai H
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1704-8. PubMed ID: 21605615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electroconvulsive therapy in Parkinson's disease and other movement disorders.
    Faber R; Trimble MR
    Mov Disord; 1991; 6(4):293-303. PubMed ID: 1758447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.